about
Pleiotropic effects of statins in the diseases of the liverDrug-Induced Liver Toxicity and Prevention by Herbal Antioxidants: An OverviewStem Cell Strategies to Evaluate Idiosyncratic Drug-induced Liver InjuryEvaluation of database-derived pathway development for enabling biomarker discovery for hepatotoxicityPharmacogenetics and Predictive Testing of Drug Hypersensitivity ReactionsKey Challenges and Opportunities Associated with the Use of In Vitro Models to Detect Human DILI: Integrated Risk Assessment and Mitigation PlansDrug-induced liver injury: Is chronic liver disease a risk factor and a clinical issue?Systematic Review and Meta-Analysis: Macrolides- and Amoxicillin/Clavulanate-induced Acute Liver Injury.Risk of Acute Liver Injury With Antiretroviral Therapy by Viral Hepatitis Status.Drug-Induced Liver Injury: Cascade of Events Leading to Cell Death, Apoptosis or NecrosisDrug-induced liver injury due to varenicline: a case report.Factors affecting drug-induced liver injury: antithyroid drugs as instances.Complementary and alternative medications in hepatitis C infection.Pharmacological effects of Trigonella foenum-graecum L. in health and disease.Risk factors for idiosyncratic drug-induced liver injury.Aspirin-Induced Acute Liver InjuryDrug-Induced Liver Injury Associated With Antidepressive Psychopharmacotherapy: An Explorative Assessment Based on Quantitative Signal Detection Using Different MedDRA Terms.An Update on Treatment of Drug-Induced Liver Injury.A multicenter assessment of single-cell models aligned to standard measures of cell health for prediction of acute hepatotoxicityFunctional role of monocytes and macrophages for the inflammatory response in acute liver injury.Bleeding complications and liver injuries during phenprocoumon treatment: a multicentre prospective observational study in internal medicine departmentsA collaborative approach to developing an electronic health record phenotyping algorithm for drug-induced liver injury.Metronidazole induced liver injury: a rare immune mediated drug reaction.Risk of oral antifungal agent-induced liver injury in TaiwaneseAcute-on-chronic liver failure in chronic hepatitis B.A prospective nationwide study of drug-induced liver injury in Korea.Drug-induced liver injury in the elderly.Idiosyncratic drug-induced liver injury: an update on the 2007 overview.Hepatobiliary transporters in drug-induced cholestasis: a perspective on the current identifying tools.The chemical, genetic and immunological basis of idiosyncratic drug-induced liver injury.Diagnosis and Management of Drug-Induced Liver Injury (DILI) in Patients with Pre-Existing Liver Disease.Characterisation of Agomelatine-Induced Increase in Liver Enzymes: Frequency and Risk Factors Determined from a Pooled Analysis of 7605 Treated Patients.Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment?Metabolomic approaches in the discovery of potential urinary biomarkers of drug-induced liver injury (DILI).The risk of acute liver injury associated with the use of antibiotics--evaluating robustness of results in the pharmacoepidemiological research on outcomes of therapeutics by a European consortium (PROTECT) project.Serum markers for mitochondrial dysfunction and cell death are possible predictive indicators for drug-induced liver injury by direct acting antivirals.Drug-Induced liver injury with hypersensitivity features has a better outcome: a single-center experience of 39 children and adolescents.Elevation of serum cytokines preceding elevation of liver enzymes in a case of drug-induced liver injury.Systematic review and meta-analysis of algorithms used to identify drug-induced liver injury (DILI) in health record databases.Agreement Among Different Scales for Causality Assessment in Drug-Induced Liver Injury.
P2860
Q26741176-39096ED8-35E5-45F5-B9B0-EFD06C3AB6A6Q26767516-61880E45-6712-41C1-805D-D216B6A13C6BQ26781923-E0A89CD2-1AB4-4D16-98DB-EA22BFF20A4AQ27027301-1EE5A488-AD1C-4A1A-BF0E-8B2F26D00FCEQ28066096-131A350D-2DE6-471F-8A9C-03D1390781C4Q28075991-1A1678E2-3636-4F58-B7D2-44EC81A4B657Q30241648-7975338D-0634-4F8F-81CF-471E73700CE4Q30251991-71094F7F-8E96-44C8-83C7-83C66C9CFB97Q33609481-B90BC4F9-2D55-4E05-B22A-FA84EB5ECBD1Q33755165-61EE48FC-84EB-4C94-9D18-40BE66F28751Q34297836-14C8F53B-07A2-4C83-B742-7AB1B93AE608Q34339590-BC56A8D1-2A33-43B7-AD5D-4F05267C12CBQ34411345-CA469A86-BDB3-4CC8-9CF1-76395A51F61AQ35010855-D9508396-103C-4E88-98DE-615668774BA5Q35168108-A78BC6DE-9F4B-4578-AC80-0222CCA13813Q35618237-1DFC11F8-A0BE-4D6F-B117-3DC131421C3AQ35809210-E5079B1D-170A-4AD7-8922-9E48DEAA50B2Q35905999-E2E326C7-92C8-44F2-AA4B-A48EAD7CE03BQ36061736-7E3904CC-8AF9-427A-8DBD-89CA52A55E40Q36331567-60A0E729-381C-482B-8BBE-593ECBF8689DQ36785642-6232E563-0C44-460F-A890-8E0162778072Q37389408-46440AFC-76EA-472A-AD01-5A457005600DQ37449762-80BC81E6-F5F8-4648-BF75-C6E1A4CF78DAQ37492058-851BC850-3D1E-49E2-82A8-EE8B051311C5Q37958079-CABFD86B-A8E3-48E9-9847-C5F697F308A6Q38021681-12D4F2BB-BBC8-433C-BEF1-D81DDEE037B9Q38068354-331C9222-CB61-4DE8-97A7-DB15430545F2Q38145274-0BF13F0D-C3E7-4522-B009-2736EC01D690Q38192698-362FD22C-4713-4424-BE0C-026E56733A38Q38651282-A24ECE20-905E-4AD9-AB47-491D1CB57986Q38811345-4696522E-B951-468F-8EDB-E4C3BE5C7BA1Q38876395-EA4997C9-BA7A-4174-9336-010C8F700679Q39234138-0A5F6F81-C96F-4A9C-9A27-27338BB85F40Q39258217-69A546D0-D16B-419C-82A3-E40B28C0BA00Q39540384-EBBD02E0-A145-4B86-858E-8E902C49AFBCQ40287891-59E9A694-F236-412D-B415-859DED8A3CD0Q40319338-9EF0A269-3548-489F-9BC3-4705809465F1Q43760744-A9AB21CA-7D72-45B2-9FA6-82DEDA629F12Q47386220-DC35092E-305A-4875-90A7-82E51AE3999CQ47594151-AEAB0349-6D3F-4D81-8D86-6CF4ED431FF4
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Epidemiology of idiosyncratic drug-induced liver injury
@ast
Epidemiology of idiosyncratic drug-induced liver injury
@en
type
label
Epidemiology of idiosyncratic drug-induced liver injury
@ast
Epidemiology of idiosyncratic drug-induced liver injury
@en
prefLabel
Epidemiology of idiosyncratic drug-induced liver injury
@ast
Epidemiology of idiosyncratic drug-induced liver injury
@en
P2860
P356
P1476
Epidemiology of idiosyncratic drug-induced liver injury
@en
P2093
Lauren N Bell
Naga Chalasani
P2860
P304
P356
10.1055/S-0029-1240002
P577
2009-10-13T00:00:00Z